Literature DB >> 17167955

Source of retreatment cases under the revised national TB control programme in Rajasthan, India, 2003.

R S Sisodia1, D F Wares, S Sahu, L S Chauhan, M Zignol.   

Abstract

BACKGROUND: Three years after state-wide DOTS coverage and achievement of global targets for detection and cure, the proportion of sputum-positive retreatment cases remained high in the north Indian state of Rajasthan. AIM: To determine source, accuracy of categorisation and treatment outcomes in Category II sputum-positive retreatment cases registered from January to March 2003 in five districts of Rajasthan.
MATERIAL AND METHODS: Two hundred consecutive Category II sputum-positive retreatment cases were identified from the tuberculosis register and interviewed using a semi-structured questionnaire.
RESULTS: Categorisation was correct in 195 (97.5%) of retreatment cases interviewed. Treatment after default (TAD) comprised 84.6% (165/195) of interviewees, with 13.3% (n = 26) relapses and 2.1% (n = 4) failure cases. Of the TAD cases, 84.8% (n = 140) had defaulted from previous treatment in the private sector. Only 6.1% (n = 10) had defaulted from Category II DOTS treatment. The most unfavourable treatment outcome seen amongst interviewees was default, as also described in the national data.
CONCLUSION: TADs constituted the majority of interviewed retreatment cases (84.6%), and were overwhelmingly being generated by irregular treatment in the private sector. Further involvement of the private sector in the DOTS programme in Rajasthan is needed to stop the creation of further retreatment cases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17167955

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  6 in total

1.  Risk factors for treatment default among re-treatment tuberculosis patients in India, 2006.

Authors:  Ugra Mohan Jha; Srinath Satyanarayana; Puneet K Dewan; Sarabjit Chadha; Fraser Wares; Suvanand Sahu; Devesh Gupta; L S Chauhan
Journal:  PLoS One       Date:  2010-01-25       Impact factor: 3.240

2.  Estimating the magnitude and direction of bias in tuberculosis drug resistance surveys conducted only in the public sector: a simulation study.

Authors:  Ted Cohen; Bethany L Hedt; Marcello Pagano
Journal:  BMC Public Health       Date:  2010-06-21       Impact factor: 3.295

3.  Modernizing surveillance of antituberculosis drug resistance: from special surveys to routine testing.

Authors:  Matteo Zignol; Wayne van Gemert; Dennis Falzon; Ernesto Jaramillo; Léopold Blanc; Mario Raviglione
Journal:  Clin Infect Dis       Date:  2011-04-01       Impact factor: 9.079

4.  Source of previous treatment for re-treatment TB cases registered under the National TB control Programme, India, 2010.

Authors:  Kuldeep Singh Sachdeva; Srinath Satyanarayana; Puneet Kumar Dewan; Sreenivas Achuthan Nair; Raveendra Reddy; Debasish Kundu; Sarabjit Singh Chadha; Ajay Kumar Madhugiri Venkatachalaiah; Malik Parmar; Lakhbir Singh Chauhan
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

5.  A systematic review of clinical outcomes on the WHO Category II retreatment regimen for tuberculosis.

Authors:  D B Cohen; J Meghji; S B Squire
Journal:  Int J Tuberc Lung Dis       Date:  2018-10-01       Impact factor: 2.373

6.  Poor outcomes in recurrent tuberculosis: More than just drug resistance?

Authors:  Danielle B Cohen; Geriant Davies; Wakisa Malwafu; Helen Mangochi; Elizabeth Joekes; Simon Greenwood; Liz Corbett; S Bertel Squire
Journal:  PLoS One       Date:  2019-05-06       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.